Netflix soars after earnings as subscriber additions top forecasts Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Aptorum Group (APM) up 59% after receiving clearance from the Public Health Agency of Canada regarding the clinical trial application to commence a Phase 1 study of ALS-4, an orally administered small molecule drug intended to treat infections caused by Staphylococcus aureus including MRSA
UP AFTER EARNINGS -
- Netflix (NFLX) up 14%
- Procter & Gamble (PG) up 1%
- Morgan Stanley (MS) up 2%
DOWN AFTER EARNINGS -
- U.S. Bancorp (USB) down 2%
LOWER -
- Gevo (GEVO) down 24% after pricing a 43.75M share registered direct offering at $8.00
- Ceragon Networks (CRNT) down 8% after Needham analyst Alex Henderson double-downgraded shares to Underperform from Buy
- CytomX Therapeutics (CTMX) down 6% after a $75M offering of common stock
Symbols:
PG - $133.56 /
-1.275 (-0.95%)
MS NFLX USB GEVO CRNT CTMX APM Keywords: Fly Intel, Wall Street, Top Stories, Stocks